ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.67
      0.00%
      US Tech 100
      17,585.60
      -0.15%
      Dow Jones
      39,056.39
      0.44%
      Brent Oil
      83.62
      0.07%
      Bitcoin
      61,304.55
      0.19%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cyteir Therapeutics Inc (CYT)

      7. Cyteir Therapeutics Inc (CYT) News

      CYT

      Cyteir Therapeutics (CYT)

      Cyteir Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CYT
      DateTimeSourceHeadlineSymbolCompany
      1:05PMiHub NewswireFeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
      03/07/20244:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
      03/07/20244:30PMBusiness WireCyteir Announces Timeline for Voluntarily Delisting from NasdaqNASDAQ:CYTCyteir Therapeutics Inc
      03/05/20246:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTCyteir Therapeutics Inc
      02/14/20247:36PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CYTCyteir Therapeutics Inc
      02/13/20247:14PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CYTCyteir Therapeutics Inc
      12/27/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
      12/14/20234:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTCyteir Therapeutics Inc
      12/07/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
      12/05/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
      11/22/20231:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTCyteir Therapeutics Inc
      11/17/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
      11/06/20234:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYTCyteir Therapeutics Inc
      10/12/20234:14PMEdgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:CYTCyteir Therapeutics Inc
      10/12/20237:52AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CYTCyteir Therapeutics Inc
      10/12/20237:51AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
      10/12/20237:30AMBusiness WireOngoing Results From a Dose Expansion Cohort of CYT-0851 in Combination With Capecitabine in Advanced Platinum-Resistant Ovarian Cancer Show Promising Clinical Activity and Generally Well Tolerated Safety ProfileNASDAQ:CYTCyteir Therapeutics Inc
      10/05/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
      10/02/20234:44PMEdgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:CYTCyteir Therapeutics Inc
      08/07/20234:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYTCyteir Therapeutics Inc
      06/30/20235:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTCyteir Therapeutics Inc
      06/30/202310:38AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CYTCyteir Therapeutics Inc
      06/30/202310:37AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CYTCyteir Therapeutics Inc
      06/30/202310:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTCyteir Therapeutics Inc
      06/30/202310:22AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTCyteir Therapeutics Inc
      06/30/20238:00AMBusiness WireCyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program and Planned Liquidation and DissolutionNASDAQ:CYTCyteir Therapeutics Inc
      06/28/20236:03PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CYTCyteir Therapeutics Inc
      06/28/20236:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTCyteir Therapeutics Inc
      06/20/20235:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTCyteir Therapeutics Inc
      06/14/20234:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTCyteir Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:CYT